According to the Summary of Product Characteristics (SmPC), constipation is classified as 'common' with Ozempic (affecting 1-10% of patients) and 'very common' with Wegovy (affecting more than 10% of patients)
For example: Ozempic pens come with a red label (contains total of 2 mg equivalent to 6 doses of 0.25 mg starting dose or 4 doses of 0.5 mg maintenance dose)
Also, glucagon promotes lipolysis in adipose tissue, providing free fatty acids as an alternative energy source during periods of low glucose availability
However, if it is exposed to heat above recommended levels, potency may decline
The following are potential risks of biweekly dosing: The return of food noise The half-life of semaglutide is approximately 7 days, which means the concentration of semaglutide in the blood remains half after this period
Gentle, osmotic laxatives are often recommended for medication-induced constipation